Literature DB >> 8229529

Effect of nitric oxide on the survival rate and incidence of lung injury in newborn lambs with persistent pulmonary hypertension.

M Zayek1, L Wild, J D Roberts, F C Morin.   

Abstract

We previously showed that inhaling nitric oxide (NO) for up to 30 minutes selectively dilates the pulmonary circulation and improves oxygenation in newborn lambs with persistent pulmonary hypertension. In the current study we determined whether inhaling NO for 23 hours increased the survival rate of newborn lambs with persistent pulmonary hypertension, oxidized hemoglobin to methemoglobin, or damaged the lungs. Persistent pulmonary hypertension was created in newborn lambs by ligating the ductus arteriosus 13 days before delivery. Six lambs were randomly selected to breathe NO at 80 parts per million for 23 hours, and 7 control lambs were untreated. Each lamb was delivered at 135 days of gestation (term is 146 days), and the lungs were ventilated at a fraction of inspired oxygen of 0.92. Each of the control lambs died before the end of the study, whereas only one of the NO-treated lambs died (p < or = 0.05). Arterial oxygen tension was greater in the NO-treated lambs by 15 minutes after delivery (63 +/- 17 vs 14 +/- 4 mm Hg). Oxygen tension increased with time in the NO-treated lambs. Inhaled NO increased the concentration of methemoglobin, but this concentration reached a plateau at 3.0% +/- 0.4%. There was evidence of early airway damage in both groups of lambs but no difference between the groups. We conclude that inhaled NO increased survival rates without increasing the incidence of acute lung injury in newborn lambs with persistent pulmonary hypertension.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8229529     DOI: 10.1016/s0022-3476(05)80393-2

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  9 in total

Review 1.  Inhaled nitric oxide treatment for preterm infants with hypoxic respiratory failure.

Authors:  R L Smyth
Journal:  Thorax       Date:  2000-08       Impact factor: 9.139

2.  Additional considerations for inhaled nitric oxide therapy in congenital diaphragmatic hernia.

Authors:  M S Irish; P Kapur; P L Glick
Journal:  Pediatr Surg Int       Date:  1997-07       Impact factor: 1.827

Review 3.  Making the most out of the least: new insights into congenital diaphragmatic hernia.

Authors:  H L Karamanoukian; S J O'Toole; B A Holm; P L Glick
Journal:  Thorax       Date:  1997-03       Impact factor: 9.139

4.  A new side effect of inhaled nitric oxide in neonates and infants with pulmonary hypertension: functional impairment of the neutrophil respiratory burst.

Authors:  P Gessler; T Nebe; A Birle; W Mueller; W Kachel
Journal:  Intensive Care Med       Date:  1996-03       Impact factor: 17.440

Review 5.  Utility of large-animal models of BPD: chronically ventilated preterm lambs.

Authors:  Kurt H Albertine
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-03-13       Impact factor: 5.464

6.  The adventitia may be a barrier specific to nitric oxide in rabbit pulmonary artery.

Authors:  R H Steinhorn; F C Morin; J A Russell
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

7.  Protein kinase Cdelta regulates endothelial nitric oxide synthase expression via Akt activation and nitric oxide generation.

Authors:  Neetu Sud; Stephen Wedgwood; Stephen M Black
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-01-11       Impact factor: 5.464

Review 8.  Inhaled NO as a therapeutic agent.

Authors:  Kenneth D Bloch; Fumito Ichinose; Jesse D Roberts; Warren M Zapol
Journal:  Cardiovasc Res       Date:  2007-05-04       Impact factor: 10.787

Review 9.  Endothelial Damage in Acute Respiratory Distress Syndrome.

Authors:  Alice G Vassiliou; Anastasia Kotanidou; Ioanna Dimopoulou; Stylianos E Orfanos
Journal:  Int J Mol Sci       Date:  2020-11-20       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.